Ledger.Open graph →

SEC Form D · filed December 21, 2015

GALECTIN THERAPEUTICS INC

Offering

—

Sold

—

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

NORCROSS, GA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Gilbert F. Amelio · Norcross, GADirector Steven G. Prelack · Norcross, GADirector Peter G. Traber · Norcross, GAExec · Director Arthur R. Greenberg · Norcross, GADirector James C. Czirr · Norcross, GAExec · Director Marc G. Rubin · Norcross, GADirector Jack W. Callicutt · Norcross, GAExec · Director John G. Mauldin · Norcross, GADirector Gilbert S. Omenn · Norcross, GADirector Kevin D. Freeman · Norcross, GADirector Gregory Mulholland · Redwood City, CADirector Paul A. Zweng · VANCOUVER, British Columbia, CanadaDirector Mark Cupta · Redwood City, CAExec · Director Margo J. Georgiadis · EMERYVILLE, CAExec · Director Scott Brady · Redwood City, CAExec · Director Roisin W. Addlestone · Grand Cayman, Cayman IslandsDirector Thomas A. Burkhart · Reno, NVDirector Carole J. Piwnica · EMERYVILLE, CADirector John F. Morgan, Jr · Hilton Head Island, SCExec · Director John F. Morgan, Sr · Hilton Head Island, SCExec · Director Scott A. Heffernan · Vancouver, British Columbia, CanadaDirector Wayne A. Johnstone · Vancouver, British Columbia, CanadaExec · Director Brenda A. Nowak · Vancouver, British Columbia, CanadaDirector Frederic G. Hewett · Vancouver, British Columbia, CanadaDirector James A. Dawson · Vancouver, British Columbia, CanadaDirector Charles L. Baxter · Mountain View, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗